European Shorting
To find out why GuruFocus thinks data on insider trade are interesting, read
| Symbol | Company | Insider | Position | Date | Buy/Sell | Shares | Trade Price ($) | Cost ($1000) | Price Change Since Trade (%) |
Yield (%) | P/E | Market Cap ($M) | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | GEVA | Synageva BioPha... | Patel Sanj K | President & CEO (Click for the stocks that their CEOs have bought) | 2013-04-08 | Sell | 31,605 | $49.68 | 1570.1 | -17.71 | 0.00 | 0.00 | 1106.8 |  Link |
| GEVA | Synageva BioPha... | Patel Sanj K | President & CEO | 2013-04-04 | Sell | 38,395 | $50.91 | 1954.7 | -19.7 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | 2013-04-01 | Sell | 4,416 | $54.31 | 239.8 | -24.73 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | Goldberg Mark Alan | SVP, Product Development | 2013-03-01 | Sell | 4,417 | $50.76 | 224.2 | -19.46 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | Patel Sanj K | President & CEO | 2013-02-21 | Sell | 70,000 | $49.19 | 3443.3 | -16.89 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | Goldberg Mark Alan | SVP, Product Development | 2013-02-01 | Sell | 4,417 | $47.75 | 210.9 | -14.39 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | Quinn Anthony | SVP, Chief Medical Officer | 2013-01-18 | Sell | 9,447 | $50.08 | 473.1 | -18.37 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | BOESS CARSTEN | SVP, CFO | 2013-01-16 | Sell | 9,927 | $49.12 | 487.6 | -16.78 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | Quinn Anthony | SVP, Chief Medical Officer | 2013-01-17 | Sell | 5,553 | $50.07 | 278 | -18.35 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | TISCH THOMAS J | Director | 2013-01-09 | Buy | 21,039 | $47.53 | 1000 | -13.99 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | BAKER JULIAN | Director, 10% Owner | 2013-01-04 | Buy | 859,720 | $47.53 | 40862.5 | -13.99 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | BAKER FELIX | Director, 10% Owner | 2013-01-04 | Buy | 859,720 | $47.53 | 40862.5 | -13.99 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | Goldberg Mark Alan | SVP, Product Development | 2013-01-02 | Sell | 4,417 | $47.52 | 209.9 | -13.97 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | Heberlig Chris | Vice President, Finance | 2012-12-19 | Sell | 4,000 | $45.93 | 183.7 | -10.99 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | Patel Sanj K | President & CEO | 2012-12-17 | Sell | 60,000 | $46.21 | 2772.6 | -11.53 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | Patel Sanj K | President & CEO | 2012-12-05 | Sell | 35,000 | $48.92 | 1712.2 | -16.43 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | Patel Sanj K | President & CEO | 2012-12-03 | Sell | 35,000 | $49.34 | 1726.9 | -17.15 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | BOESS CARSTEN | SVP, CFO | 2012-10-16 | Sell | 9,927 | $50.13 | 497.6 | -18.45 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | Heberlig Chris | Vice President, Finance | 2012-10-17 | Sell | 4,000 | $49.66 | 198.6 | -17.68 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | Heberlig Chris | Vice President, Finance | 2012-09-04 | Sell | 1,000 | $49.1 | 49.1 | -16.74 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | Patel Sanj K | President & CEO | 2012-09-04 | Sell | 70,000 | $49.47 | 3462.9 | -17.36 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | Quinn Anthony | SVP, Chief Medical Officer | 2012-07-27 | Sell | 7,500 | $50.2 | 376.5 | -18.57 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | Quinn Anthony | SVP, Chief Medical Officer | 2012-07-20 | Sell | 2,500 | $50 | 125 | -18.24 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | BOESS CARSTEN | SVP, CFO | 2012-07-18 | Sell | 6,618 | $48.82 | 323.1 | -16.26 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | BAKER FELIX | Director, 10% Owner | 2012-07-13 | Buy | 886,000 | $41.2 | 36503.2 | -0.78 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | BAKER JULIAN | Director, 10% Owner | 2012-07-13 | Buy | 886,000 | $41.2 | 36503.2 | -0.78 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | TISCH THOMAS J | Director | 2012-07-12 | Buy | 73,000 | $41.2 | 3007.6 | -0.78 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | TISCH DANIEL R | 10% Owner | 2012-07-12 | Sell | 29,200 | $46.75 | 1365.1 | -12.56 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | TISCH DANIEL R | 10% Owner | 2012-07-11 | Sell | 10,000 | $45.73 | 457.3 | -10.61 | 0.00 | 0.00 | 1106.8 | Link |
| GEVA | Synageva BioPha... | TISCH DANIEL R | 10% Owner | 2012-07-10 | Sell | 10,000 | $45.23 | 452.3 | -9.62 | 0.00 | 0.00 | 1106.8 | Link |
| Guru Name | Portfolio Date* | Current Shares (?) | % of Total Assets (?) | Change from Last Holdings (?) | |
|---|---|---|---|---|---|
| Columbia Wanger | 2013-03-31 | 1,927,289 | 0.46% | +16.09% | |
| Jim Simons | 2013-03-31 | 46,901 | 0.01% | -67.16% | |
 Most recent portfolio changes are included for Premium Members only!
| |||||
Feedback
My Portfolios
Browse Gurus
Insider Trade Rss Update
Bookmark
This page has been successfully added into your 
RSS
Add Notes, Comments or Ask Questions
Comments